Attomarker
Attomarker provides rapid, quantified point-of-care blood and saliva testing to give clinicians and consumers fast, actionable biomarker results. It uses a patented gold-based nanophotonic platform with disposable credit-card–sized chips read by a pocket-sized, phone-docked reader and companion mobile app to interpret assays in roughly 5–10 minutes. The system supports multiple simultaneous biomarker assays (up to eight per sample), integrates with electronic patient record systems, and links to an AI symptom checker and teleconsultation workflows. Attomarker is positioned as a medtech point-of-care diagnostics solution for clinics, pharmacies and direct-to-consumer use, with an initial pipeline including Long Covid, allergy, pregnancy and CRP tests and plans for broader infectious and chronic disease panels.
Attomarker
Attomarker provides rapid, quantified point-of-care blood and saliva testing to give clinicians and consumers fast, actionable biomarker results. It uses a patented gold-based nanophotonic platform with disposable credit-card–sized chips read by a pocket-sized, phone-docked reader and companion mobile app to interpret assays in roughly 5–10 minutes. The system supports multiple simultaneous biomarker assays (up to eight per sample), integrates with electronic patient record systems, and links to an AI symptom checker and teleconsultation workflows. Attomarker is positioned as a medtech point-of-care diagnostics solution for clinics, pharmacies and direct-to-consumer use, with an initial pipeline including Long Covid, allergy, pregnancy and CRP tests and plans for broader infectious and chronic disease panels.